Hepatitis C-Associated Rheumatic Disorders

Keyphrases

• Hepatitis C 100%
• Rheumatic Disorders 100%
• Hepatitis C Virus 66%
• Cyclosporine 33%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 33%
• Arthritis 33%
• Current Treatment 33%
• Autoimmune Disease 33%
• Vasculitis 33%
• Causative Agents 33%
• Anti-tumor Necrosis Factor (anti-TNF) 33%
• Infected Patients 33%
• Treatment Efficacy 33%
• Methotrexate 33%
• Rituximab 33%
• Arthralgia 33%
• Treatment Options 33%
• Autoimmune Phenomena 33%
• Renal Disease 33%
• Fibromyalgia 33%
• Liver Disease 33%
• Antiretroviral Therapy 33%
• Dermatological Diseases 33%
• Hematological Diseases 33%
• Hepatitis C Virus Infection 33%
• D-penicillamine 33%
• Myalgia 33%
• Hydroxychloroquine 33%
• Treatment Safety 33%
• Treatment Indication 33%
• Disorder Phenomena 33%
• Sicca Syndrome 33%
• Low-dose Corticosteroids 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Hepatitis C 100%
• Hepatitis C Virus 100%
• Tumor Necrosis Factor 50%
• Prevalence 50%
• Non-Steroidal Anti-Inflammatory Drug 50%
• Arthritis 50%
• Autoimmune Disease 50%
• Rituximab 50%
• Arthralgia 50%
• Vasculitis 50%
• Liver Disease 50%
• Ciclosporin 50%
• Antiviral Therapy 50%
• Dermatological Agent 50%
• Kidney Disease 50%
• Methotrexate 50%
• Penicillamine 50%
• Hydroxychloroquine 50%
• Fibromyalgia 50%
• Myalgia 50%
• Sjoegren Syndrome 50%